A busy Monday spans evolving polymyalgia rheumatica, structured antimicrobial selection, bronchiectasis and burn coverage.
A normal first ESR and CRP do not close the case when localised pain evolves into bilateral proximal morning stiffness.
A busy Monday starts the week with an unusually broad clinical spread: evolving inflammatory pain, antimicrobial prescribing, chronic airway disease, burn reconstruction, uro-oncology, adult ADHD, cardiovascular prevention and childhood bone fragility. Today also marks the first appearance of ID:IOTS in the Daily Clinical Briefing, bringing a practical microbe–host–drug framework to antimicrobial decision-making.
The musculoskeletal reasoning case begins with pain that changes over time. An older adult may initially have localised hip pain with normal radiographs and inflammatory markers, only for the syndrome to evolve into bilateral hip, shoulder and neck stiffness with raised ESR and CRP. Morning stiffness that improves with movement supports an inflammatory process. Serial reassessment matters because the correct diagnosis may only become visible as the pattern develops.
Polymyalgia rheumatica becomes more likely when proximal symptoms dominate, peripheral findings remain limited and low-dose corticosteroid treatment produces rapid functional improvement. Degenerative findings on spinal imaging should not be accepted as causal when the neurological examination and symptom pattern do not fit. Once corticosteroids are started, clinicians should screen for associated giant cell arteritis and anticipate complications such as significant hyperglycaemia in patients with diabetes.
The ID:IOTS episode provides a repeatable structure for antimicrobial selection. First decide whether infection is actually present and which pathogen group is plausible. Then consider host factors including allergy, immune status, kidney and liver function, pregnancy, swallowing and adherence. Finally assess drug factors such as spectrum, route, dosing, duration, interactions, adverse effects and penetration into the infected tissue. Straightforward empirical treatment should usually begin with local guidance, while culture results should support narrowing when a less broad option is safe and effective.
Bronchiectasis applies the same principle to recurrent respiratory infection. Assessment should establish the patient’s baseline sputum volume, colour and breathlessness before deciding that deterioration represents an infective exacerbation. HRCT provides the diagnostic anatomical detail, while sputum cultures during stable periods and exacerbations help define airway flora and guide treatment. Airway clearance remains central, with specialist respiratory input needed when resistant organisms, frequent exacerbations or complications emerge.
The burns episode moves from infection treatment to wound protection. Skin substitutes can provide a temporary barrier, optimise the wound bed or extend limited donor resources, but they do not remove the need for autologous skin in definitive closure. Product selection should follow the immediate clinical goal and the tissue being replaced rather than novelty or acquisition price alone. Early success is judged through graft or substitute take, with infection, time to closure, scar quality, function and total care cost assessed separately.
The remaining episodes add several clinic-facing checks. PSA should be explained as a non-specific risk marker, and even a single resolved episode of visible haematuria should keep urinary tract malignancy in the differential. Adult concentration problems require reconstruction of childhood function and active assessment for sleep, substance, mood, obsessive or psychotic causes. In cardiovascular prevention, apoB and lipoprotein(a) can expose risk that LDL-C or a 10-year calculator understates. In children, recurrent minimal-trauma fractures with blue-grey sclera, hypermobility or fragile teeth should prompt assessment for osteogenesis imperfecta rather than treatment as a series of unrelated injuries.
Oncology, general surgery and basic-science learners get a practical overview of prostate cancer and wider uro-oncology. PSA is treated as a risk marker rather than a diagnosis, while Gleason grade, anatomical stage, visible haematuria, bladder field risk, kidney-preserving surgery and multidisciplinary decision-making shape investigation and treatment.
General surgery, critical-care and dermatology teams get a framework for extensive burn coverage when donor skin is limited. Temporary barriers, dermal templates, cellular products and autologous grafts are organised around wound bed, treatment goal, sequencing, graft take, infection, function and the full cost of care.
Acute medicine, emergency and rheumatology clinicians get an evolving case of proximal pain and stiffness. Repeat inflammatory markers, morning stiffness, clinical-radiological correlation and serial reassessment help distinguish polymyalgia rheumatica from local hip disease, neurological pathology and elderly-onset rheumatoid arthritis.
Infectious-diseases, general-practice and medical-education clinicians get a structured antimicrobial-prescribing framework. Likely pathogen, culture data, local resistance, allergy, organ function, pregnancy, route, tissue penetration, adverse effects and stewardship are brought together before choosing or narrowing treatment.
Respiratory, acute medicine and infectious-diseases learners get a practical review of chronic productive cough, coarse crackles and recurrent exacerbations. HRCT, sputum microbiology, investigation of the underlying cause, airway-clearance techniques and targeted antibiotics form the core assessment and management pathway.
Psychiatry and critical-appraisal clinicians get a careful approach to attention problems first reported in adulthood. Developmental history and collateral information help identify overlooked childhood ADHD, while sleep disorders, substance use, mood disorders, obsessive symptoms and psychosis remain important alternative explanations.
A low short-term cardiovascular risk score can under call risk in younger adults. ApoB, lipoprotein(a), metabolic syndrome features, and coronary artery calcium refine prevention decisions, and any positive calcium score in a younger patient should be treated as a meaningful red flag.
Paediatric and trauma-and-orthopaedic clinicians get a focused review of recurrent fractures after minimal trauma. Blue-grey sclera, joint hypermobility, short stature, dental fragility, bone deformity and hearing loss support recognition of a type 1 collagen disorder requiring coordinated multidisciplinary care.
Before prescribing an antimicrobial, state the suspected syndrome, likely pathogen group and whether treatment is empirical or culture-directed. Then check host factors and tissue penetration before accepting the default option. When musculoskeletal pain returns with spreading proximal stiffness, rebuild the problem representation, repeat inflammatory markers and screen for associated giant cell arteritis. In a child with recurrent low-energy fractures, examine for blue-grey sclera, hypermobility, short stature and dental fragility.
An older adult develops bilateral shoulder and hip stiffness, raised ESR and CRP, negative RF and anti-CCP antibodies, and rapid functional improvement after low-dose corticosteroid treatment. What is the most likely diagnosis, and what associated condition requires active screening?
The most likely diagnosis is polymyalgia rheumatica. The patient should also be screened for features suggesting giant cell arteritis.
A culture-proven bone and joint infection is susceptible to several oral antimicrobials, but the available agents differ in how reliably they reach the infected site. Which drug factor should most directly influence selection?
Tissue penetration. Microbiological susceptibility alone is insufficient if the antimicrobial does not achieve adequate concentrations in bone and joint tissue.
A child has recurrent long-bone fractures after minor trauma, blue-grey sclera, joint hypermobility and short stature. What diagnosis best fits, and which structural protein is usually affected?
The diagnosis is osteogenesis imperfecta, usually caused by abnormalities affecting type 1 collagen.
.svg)